Sanofi (SNY) Tops Q2 EPS by 100c
Tweet
Share
E-mail
Get Alerts SNY Hot Sheet
Join SI Premium – FREE
Sanofi (NASDAQ: SNY) reported Q2 EPS of EUR2.09, EUR1.00 better than the analyst estimate of EUR1.09. Revenue for the quarter came in at EUR11.6 billion versus the consensus estimate of EUR13.02 billion.
For earnings history and earnings-related data on Sanofi (SNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helios Technologies (HLIO) Tops Q2 EPS by 8c; raises guidance
- AlTi Global (ALTI) Misses Q1 EPS by 37c
- Jade Biosciences (JBIO) Misses Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
